{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lipoprotéines LDL : Questions médicales les plus fréquentes",
"headline": "Lipoprotéines LDL : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lipoprotéines LDL : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-18",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lipoprotéines LDL"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipoprotéines",
"url": "https://questionsmedicales.fr/mesh/D008074",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines",
"code": {
"@type": "MedicalCode",
"code": "D008074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cholestérol LDL",
"alternateName": "Cholesterol, LDL",
"url": "https://questionsmedicales.fr/mesh/D008078",
"about": {
"@type": "MedicalCondition",
"name": "Cholestérol LDL",
"code": {
"@type": "MedicalCode",
"code": "D008078",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.550.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines LDL",
"alternateName": "Lipoproteins, LDL",
"code": {
"@type": "MedicalCode",
"code": "D008077",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sotirios Tsimikas",
"url": "https://questionsmedicales.fr/author/Sotirios%20Tsimikas",
"affiliation": {
"@type": "Organization",
"name": "Vascular Medicine Program, Sulpizio Cardiovascular Center, Division of Cardiology, University of California San Diego, La Jolla, California, USA."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Maija Ruuth",
"url": "https://questionsmedicales.fr/author/Maija%20Ruuth",
"affiliation": {
"@type": "Organization",
"name": "From the Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland (M.R., L.Ä., F.T.-S., P.T.K., K.Ö.)."
}
},
{
"@type": "Person",
"name": "Katariina Öörni",
"url": "https://questionsmedicales.fr/author/Katariina%20%C3%96%C3%B6rni",
"affiliation": {
"@type": "Organization",
"name": "From the Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland (M.R., L.Ä., F.T.-S., P.T.K., K.Ö.)."
}
},
{
"@type": "Person",
"name": "Jose L Flores-Guerrero",
"url": "https://questionsmedicales.fr/author/Jose%20L%20Flores-Guerrero",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Color Vision in the Mountains.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37775373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.wem.2023.08.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "A diagnostic model based on color vision examination for dysthyroid optic neuropathy using Hardy-Rand-Rittler color plates.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37103624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06062-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "The causal mutation in ARR3 gene for high myopia and progressive color vision defect.",
"datePublished": "2023-06-02",
"url": "https://questionsmedicales.fr/article/37268727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-36141-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spectral Filter Selection Based on Human Color Vision for Spectral Reflectance Recovery.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37299952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23115225"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of contrast sensitivity in patients with congenital red-green color vision deficiency.",
"datePublished": "2024-06-25",
"url": "https://questionsmedicales.fr/article/38916772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-024-03160-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D008074"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lipoprotéines LDL",
"item": "https://questionsmedicales.fr/mesh/D008077"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lipoprotéines LDL - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lipoprotéines LDL",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lipoprotéines LDL",
"description": "Comment mesurer le taux de LDL ?\nQuels sont les niveaux normaux de LDL ?\nQuand faut-il vérifier le LDL ?\nQuels tests évaluent le LDL ?\nLe LDL peut-il être mesuré à domicile ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Color+Vision#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lipoprotéines LDL",
"description": "Quels symptômes indiquent un taux élevé de LDL ?\nLe LDL affecte-t-il la peau ?\nLe LDL peut-il causer des crises cardiaques ?\nQuels signes d'alerte pour le cœur ?\nLe LDL est-il lié à l'AVC ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Color+Vision#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lipoprotéines LDL",
"description": "Comment prévenir un taux élevé de LDL ?\nLe tabagisme influence-t-il le LDL ?\nLe stress affecte-t-il le LDL ?\nLes examens réguliers sont-ils importants ?\nL'hydratation influence-t-elle le LDL ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Color+Vision#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lipoprotéines LDL",
"description": "Quels médicaments réduisent le LDL ?\nLes changements alimentaires aident-ils le LDL ?\nLe sport influence-t-il le LDL ?\nLes suppléments de phytostérols sont-ils efficaces ?\nLes traitements naturels existent-ils pour le LDL ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Color+Vision#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lipoprotéines LDL",
"description": "Quelles sont les complications d'un LDL élevé ?\nLe LDL peut-il causer des maladies rénales ?\nLe LDL est-il lié à la démence ?\nComment le LDL affecte-t-il la circulation sanguine ?\nLe LDL peut-il affecter la vision ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Color+Vision#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lipoprotéines LDL",
"description": "Quels sont les principaux facteurs de risque pour le LDL ?\nL'âge influence-t-il le LDL ?\nLe diabète affecte-t-il le LDL ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le LDL ?",
"url": "https://questionsmedicales.fr/mesh/D008077?mesh_terms=Color+Vision#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de LDL ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de LDL est mesuré par une analyse de sang après un jeûne de 9 à 12 heures."
}
},
{
"@type": "Question",
"name": "Quels sont les niveaux normaux de LDL ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux de LDL inférieur à 1,6 g/L est considéré comme normal pour la plupart des adultes."
}
},
{
"@type": "Question",
"name": "Quand faut-il vérifier le LDL ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de vérifier le LDL tous les 4 à 6 ans chez les adultes à risque normal."
}
},
{
"@type": "Question",
"name": "Quels tests évaluent le LDL ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le profil lipidique évalue le LDL, le HDL et les triglycérides dans le sang."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il être mesuré à domicile ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dispositifs de test à domicile peuvent mesurer le cholestérol, y compris le LDL."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un taux élevé de LDL ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de LDL est souvent asymptomatique, mais peut mener à des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Le LDL affecte-t-il la peau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépôts de cholestérol peuvent apparaître sur la peau, appelés xanthomes, en cas d'excès de LDL."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il causer des crises cardiaques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un taux élevé de LDL contribue à l'athérosclérose, augmentant le risque de crise cardiaque."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour le cœur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Essoufflement, fatigue excessive et douleurs dans le bras gauche peuvent signaler un problème cardiaque."
}
},
{
"@type": "Question",
"name": "Le LDL est-il lié à l'AVC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un taux élevé de LDL augmente le risque d'accident vasculaire cérébral (AVC)."
}
},
{
"@type": "Question",
"name": "Comment prévenir un taux élevé de LDL ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, faire de l'exercice et adopter une alimentation équilibrée sont essentiels."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le LDL ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le LDL et diminue le HDL, augmentant le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le LDL ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à des niveaux élevés de LDL et à d'autres problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers aident à surveiller le taux de LDL et à prévenir les maladies."
}
},
{
"@type": "Question",
"name": "L'hydratation influence-t-elle le LDL ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation est importante pour la santé globale, mais son effet direct sur le LDL est limité."
}
},
{
"@type": "Question",
"name": "Quels médicaments réduisent le LDL ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les statines sont couramment prescrites pour abaisser le taux de LDL dans le sang."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils le LDL ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fibres et faible en graisses saturées peut réduire le LDL."
}
},
{
"@type": "Question",
"name": "Le sport influence-t-il le LDL ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut aider à abaisser le LDL et améliorer le profil lipidique global."
}
},
{
"@type": "Question",
"name": "Les suppléments de phytostérols sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les phytostérols peuvent réduire le LDL lorsqu'ils sont intégrés à un régime alimentaire sain."
}
},
{
"@type": "Question",
"name": "Les traitements naturels existent-ils pour le LDL ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes comme l'ail et le thé vert peuvent aider à réduire le LDL, mais avec prudence."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'un LDL élevé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un LDL élevé peut entraîner des maladies cardiaques, des AVC et des problèmes vasculaires."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il causer des maladies rénales ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'athérosclérose due à un LDL élevé peut affecter la circulation sanguine vers les reins."
}
},
{
"@type": "Question",
"name": "Le LDL est-il lié à la démence ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent qu'un LDL élevé pourrait être associé à un risque accru de démence."
}
},
{
"@type": "Question",
"name": "Comment le LDL affecte-t-il la circulation sanguine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un LDL élevé peut provoquer des dépôts dans les artères, réduisant le flux sanguin et augmentant le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Le LDL peut-il affecter la vision ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de LDL peuvent contribuer à des problèmes oculaires, comme l'athérosclérose rétinienne."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le LDL ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme, une alimentation riche en graisses saturées et le manque d'exercice sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le LDL ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'avoir un LDL élevé augmente avec l'âge, surtout après 45 ans chez les hommes."
}
},
{
"@type": "Question",
"name": "Le diabète affecte-t-il le LDL ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le LDL et le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des niveaux élevés de LDL et à des problèmes de santé associés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le LDL ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiaques peuvent augmenter le risque de LDL élevé."
}
}
]
}
]
}
From the Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland (M.R., L.Ä., F.T.-S., P.T.K., K.Ö.).
Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences (F.T.-S., R.K., K.Ö.), University of Helsinki, Finland.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Electronic address: mengxia45@163.com.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Electronic address: yongjunwang@ncrcnd.org.cn.
This Lessons from History article uses science, aviation, medicine, and mountaineering sources to describe some of the effects of hypoxia, illumination, and other environmental conditions on the eye, ...
To investigate color vision deficiency and the value of Hardy-Rand-Rittler (HRR) color plates in monitoring dysthyroid optic neuropathy (DON) to improve the diagnosis of DON....
The participants were divided into DON and non-DON (mild and moderate-to-severe) groups. All the subjects underwent HRR color examination and comprehensive ophthalmic examinations. The random forest a...
Thirty DON patients (57 eyes) and sixty non-DON patients (120 eyes) were enrolled. The HRR score was lower in DON patients than in non-DON patients (12.1 ± 6.2 versus 18.7 ± 1.8, p < 0.001). The major...
The HRR test was valid as screening method for DON. The multifactor decision tree based on the HRR test improved the diagnostic efficacy for DON. An HRR score of less than 12 and red-green deficiency ...
The ARR3 gene, also known as cone arrestin, belongs to the arrestin family and is expressed in cone cells, inactivating phosphorylated-opsins and preventing cone signals. Variants of ARR3 reportedly c...
Spectral filters are an important part of a multispectral acquisition system, and the selection of suitable filters can improve the spectral recovery accuracy. In this paper, we propose an efficient h...
To evaluate mesopic and photopic contrast sensitivity in patients with congenital red-green color vision deficiency regarding with and without glare conditions and to compare these findings with age- ...
Patients with congenital red-green color vision deficiency and age- and gender-matched healthy controls were included in this cross-sectional comparative study. Contrast sensitivity measurements were ...
Twenty one patients with color vision deficiency (13 deuteranopic, 8 protanopic) and 22 age- and gender-matched healthy controls were included in the study. The mean age was 35.2 ± 13.5 years in the p...
Mesopic and photopic contrast sensitivity values of patients with congenital red-green color vision deficiency were similar to healthy controls regarding with and without glare conditions....
To achieve computer vision color constancy (CVCC), it is vital but challenging to estimate scene illumination from a digital image, which distorts the true color of an object. Estimating illumination ...
Human photoreceptors consist of cones, rods, and melanopsin-expressing intrinsically photosensitive retinal ganglion cells (ipRGCs). First studied in circadian regulation and pupillary control, ipRGCs...
A large body of recent research has demonstrated that patients with schizophrenia exhibit significant changes in visual function and ocular tissue structure in the early stages of onset. It is therefo...
This study was designed to analyze the characteristics of iris structure, color vision function and cognitive function, as well as the changes therein in patients with the first-episode drug-free schi...
This study recruited 61 patients (22 males) with first-episode schizophrenia. Prior to the commencement of treatment with antipsychotic drugs, the Montreal Cognitive Assessment (MoCA) and Farnsworth-M...
On the basis of structural iris characteristics, 61 patients were classified as follows: 28 patients without iris crypts and 33 with iris crypts; 35 without iris pigment dots and 26 with iris pigment ...
The findings of this study demonstrated that color vision function of patients with schizophrenia improved with the improvement of cognitive function. The structural characteristics of the iris with c...
Spherical geometry, adaptive optics, and highly dense network of neurons bridging the eye with the visual cortex, are the primary features of human eyes which enable wide field-of-view (FoV), low aber...
Perceptual learning is the improvement of perceptual performance after repeated practice on a perceptual task. Studies on perceptual learning in color vision are limited. In this study, we measured th...